AbbVie Inc. (NEO:ABBV)

United States Steel Statistics

Total Valuation

AbbVie has a market cap or net worth of CAD 483.44 billion. The enterprise value is 571.87 billion.

Market Cap	483.44B
Enterprise Value	571.87B

Important Dates

The last earnings date was Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 95.21 and the forward PE ratio is 15.11.

PE Ratio	95.21
Forward PE	15.11
PS Ratio	6.08
PB Ratio	-2,568.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.60, with an EV/FCF ratio of 22.99.

EV / Earnings	112.63
EV / Sales	7.11
EV / EBITDA	14.60
EV / EBIT	20.95
EV / FCF	22.99

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	2.48
Debt / FCF	3.87
Interest Coverage	6.92

Financial Efficiency

Return on equity (ROE) is 112.85% and return on invested capital (ROIC) is 16.70%.

Return on Equity (ROE)	112.85%
Return on Assets (ROA)	8.87%
Return on Invested Capital (ROIC)	16.70%
Return on Capital Employed (ROCE)	20.33%
Revenue Per Employee	1.45M
Profits Per Employee	92,321
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	3.65

Taxes

Income Tax	-1.01B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.94% in the last 52 weeks. The beta is 0.48, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+2.94%
50-Day Moving Average	26.95
200-Day Moving Average	27.00
Relative Strength Index (RSI)	61.88
Average Volume (20 Days)	6,272

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.46

Income Statement

In the last 12 months, AbbVie had revenue of CAD 79.55 billion and earned 5.08 billion in profits. Earnings per share was 2.86.

Revenue	79.55B
Gross Profit	56.68B
Operating Income	27.01B
Pretax Income	4.13B
Net Income	5.08B
EBITDA	38.29B
EBIT	27.01B
Earnings Per Share (EPS)	2.86

Balance Sheet

The company has 8.82 billion in cash and 96.27 billion in debt, giving a net cash position of -87.45 billion.

Cash & Cash Equivalents	8.82B
Total Debt	96.27B
Net Cash	-87.45B
Net Cash Per Share	n/a
Equity (Book Value)	-188.21M
Book Value Per Share	-0.14
Working Capital	-14.33B

Cash Flow

In the last 12 months, operating cash flow was 26.30 billion and capital expenditures -1.42 billion, giving a free cash flow of 24.88 billion.

Operating Cash Flow	26.30B
Capital Expenditures	-1.42B
Free Cash Flow	24.88B
FCF Per Share	n/a

Margins

Gross margin is 71.25%, with operating and profit margins of 33.95% and 6.45%.

Gross Margin	71.25%
Operating Margin	33.95%
Pretax Margin	5.19%
Profit Margin	6.45%
EBITDA Margin	48.13%
EBIT Margin	33.95%
FCF Margin	31.27%

Dividends & Yields

AbbVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	301.30%
Buyback Yield	-0.03%
Shareholder Yield	n/a
Earnings Yield	1.05%
FCF Yield	5.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	6